Saturday, April 4, 2009

Pharmaceutical companies push forward and other news

Here's a news item/press release from last week:

Bioniche Completes Recruitment in First Phase III Clinical Trial with Urocidin(TM)

A Canadian bio-pharmaceutical company is shepherding through the system a previously fast-tracked by FDA drug for treatment of non-muscle-invasive bladder cancer that is refractory (unresponsive) to the current standard immunotherapy - Bacillus Calmette-Guérin (BCG).

Speaking of bladder cancer in the news, we also have a former NBA player having surgery for bladder cancer, some positive news about recurrence concerns and FoxNews along with a few other lesser source can't resist the biblical puns in reporting of the frankincense oil bladder cancer discovery.

And in great news for dogs, Professors at Purdue University are researching causes of bladder cancer in some purebred dogs. The news isn't just great for dogs, as according to the researchers,
they have already identified some regions of the DNA that is different between dogs with cancer and dogs without cancer, and the hope is that this will help them understand the genetic differences in humans that can lead to the development of bladder cancer. Hang in there, Westies, Shelties and beagles, science is on its way to save you!

No comments: